Skip to main content
Erschienen in: Journal of NeuroVirology 5/2016

01.10.2016

Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients

verfasst von: Nihal Olgac Dundar, Pinar Gencpinar, Nilgun Sallakci, Ozgur Duman, Senay Haspolat, Banu Anlar, Olcay Yegin

Erschienen in: Journal of NeuroVirology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

The two polymorphisms [IL-12 (-1188) A/C and the IFN-γ (+874) A/T)] are known to have functional consequences and henceforth were analyzed in subacute sclerosing panencephalitis (SSPE) patients to reveal a possible relation with these polymorphisms and this debilitating disease. For the IL-12 (-1188) A/C polymorphism, 78 patients and 90 healthy individuals were analyzed. An increase in the AA genotype was determined (p = 0.02, OR = 2.06). There was also a statistically significant difference between the control group and the patients with respect to the allele frequencies (p = 0.04, OR = 1.65). For the IFN-γ (+874) A/T polymorphism, 69 SSPE patients and 115 controls were studied and there was not a significant difference between the two groups. Our findings suggested that not the IFN-γ (+874) A/T but the IL-12 (-1188) A/C polymorphism is correlated with SSPE and having an AA genotype or A allele decreases the risk of developing SSPE by 2.06- and 1.65-fold, respectively.
Literatur
Zurück zum Zitat Anlar B, Söylemezoğlu F, Elibol B, Dalkara T, Aysun S, Köse G, Belen D, Yalaz K (1999) Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients. Neuropediatrics 305:239–242CrossRef Anlar B, Söylemezoğlu F, Elibol B, Dalkara T, Aysun S, Köse G, Belen D, Yalaz K (1999) Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients. Neuropediatrics 305:239–242CrossRef
Zurück zum Zitat Atabani SF, Byrnes AA, Jaye A, Kidd IM, Magnusen AF, Whittle H, Karp CL (2001) Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 184:1–9CrossRefPubMed Atabani SF, Byrnes AA, Jaye A, Kidd IM, Magnusen AF, Whittle H, Karp CL (2001) Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 184:1–9CrossRefPubMed
Zurück zum Zitat Ayata M, Hayashi K, Seto T, Murata R, Ogura H (1998) The matrix gene expression of subacute sclerosing panencephalitis (SSPE) virus (Osaka-1 strain): a comparison of two sibling viruses isolated from different lobes of an SSPE brain. Microbiol Immunol 42:773–780CrossRefPubMed Ayata M, Hayashi K, Seto T, Murata R, Ogura H (1998) The matrix gene expression of subacute sclerosing panencephalitis (SSPE) virus (Osaka-1 strain): a comparison of two sibling viruses isolated from different lobes of an SSPE brain. Microbiol Immunol 42:773–780CrossRefPubMed
Zurück zum Zitat Baczko K, Lampe J, Liebert UG, Brinckmann U, ter Meulen V, Pardowitz I, Budka H, Cosby SL, Isserte S, Rima BK (1993) Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 197:188–195CrossRefPubMed Baczko K, Lampe J, Liebert UG, Brinckmann U, ter Meulen V, Pardowitz I, Budka H, Cosby SL, Isserte S, Rima BK (1993) Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 197:188–195CrossRefPubMed
Zurück zum Zitat Dyken PR (2001) Neuroprogressive disease of postinfectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev 7:217–225CrossRefPubMed Dyken PR (2001) Neuroprogressive disease of postinfectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev 7:217–225CrossRefPubMed
Zurück zum Zitat Finke D, Brinckmann UG, ter Meulen V, Liebert UG (1995) Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 69:5469–5474PubMedPubMedCentral Finke D, Brinckmann UG, ter Meulen V, Liebert UG (1995) Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 69:5469–5474PubMedPubMedCentral
Zurück zum Zitat Graves M (1984) Subacute sclerosing panencephalitis. Neurol Clin 2:267–280PubMed Graves M (1984) Subacute sclerosing panencephalitis. Neurol Clin 2:267–280PubMed
Zurück zum Zitat Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good RA, Takeshita K (2000) Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J NeuroVirol 6:121–126CrossRefPubMed Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good RA, Takeshita K (2000) Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J NeuroVirol 6:121–126CrossRefPubMed
Zurück zum Zitat Hasegawa S, Mori N, Satomi M, Jiang DP, Hotta H, Matsushige T, Ichiyama T (2011) Interferon production by cells infected with subacute sclerosing panencephalitis (SSPE) virus or measles virus. Cytokine 56:676–679CrossRefPubMed Hasegawa S, Mori N, Satomi M, Jiang DP, Hotta H, Matsushige T, Ichiyama T (2011) Interferon production by cells infected with subacute sclerosing panencephalitis (SSPE) virus or measles virus. Cytokine 56:676–679CrossRefPubMed
Zurück zum Zitat Inoue T, Kira R, Nakao F, Ihara K, Bassuny WM, Kusuhara K, Nihei K, Takeshita K, Hara T (2002) Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 59:822–827CrossRefPubMed Inoue T, Kira R, Nakao F, Ihara K, Bassuny WM, Kusuhara K, Nihei K, Takeshita K, Hara T (2002) Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 59:822–827CrossRefPubMed
Zurück zum Zitat Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154:116–127PubMed Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154:116–127PubMed
Zurück zum Zitat McQuaid S, McMahon J, Herron B, Cosby SL (1997) Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol Appl Neurobiol 2:218–224CrossRef McQuaid S, McMahon J, Herron B, Cosby SL (1997) Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol Appl Neurobiol 2:218–224CrossRef
Zurück zum Zitat Millar EL, Rennick LJ, Weissbrich B, Schneider-Schaulies J, Duprex WP, Rima BK (2015) The phosphoprotein genes of measles viruses from subacute sclerosing panencephalitis cases encode functional as well as non-functional proteins and display reduced editing. Virus Res 211:29–37CrossRefPubMed Millar EL, Rennick LJ, Weissbrich B, Schneider-Schaulies J, Duprex WP, Rima BK (2015) The phosphoprotein genes of measles viruses from subacute sclerosing panencephalitis cases encode functional as well as non-functional proteins and display reduced editing. Virus Res 211:29–37CrossRefPubMed
Zurück zum Zitat Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB (2000) Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J Virol 74:7478–7484CrossRefPubMedPubMedCentral Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB (2000) Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J Virol 74:7478–7484CrossRefPubMedPubMedCentral
Zurück zum Zitat Patterson CE, Lawrence DM, Echols LA, Rall GF (2002) Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 76:4497–4506CrossRefPubMedPubMedCentral Patterson CE, Lawrence DM, Echols LA, Rall GF (2002) Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 76:4497–4506CrossRefPubMedPubMedCentral
Zurück zum Zitat Saruhan-Direskeneli G, Gurses C, Demirbilek V, Yentur SP, Yilmaz G, Onal E, Yapici Z, Yalcinkaya C, Cokar O, Akman-Demir G, Gokyigit A (2005) Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis. Cytokine 32:104–110CrossRefPubMed Saruhan-Direskeneli G, Gurses C, Demirbilek V, Yentur SP, Yilmaz G, Onal E, Yapici Z, Yalcinkaya C, Cokar O, Akman-Demir G, Gokyigit A (2005) Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis. Cytokine 32:104–110CrossRefPubMed
Zurück zum Zitat Schneider-Schaulies J, Niewiesk S, Schneider-Schaulies S, ter Meulen V (1999) Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J Neurovirol 613–22 Schneider-Schaulies J, Niewiesk S, Schneider-Schaulies S, ter Meulen V (1999) Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J Neurovirol 613–22
Zurück zum Zitat Schneider-Schaulies J, ter Meulen V, Schneider-Schaulies S (2003) Measles infection of the central nervous system. J NeuroVirol 9:247–252CrossRefPubMed Schneider-Schaulies J, ter Meulen V, Schneider-Schaulies S (2003) Measles infection of the central nervous system. J NeuroVirol 9:247–252CrossRefPubMed
Zurück zum Zitat Schnorr JJ, Xanthakos S, Keikavoussi P, Kämpgen E, ter Meulen V, Schneider-Schaulies S (1997) Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A 94:5326–5331CrossRefPubMedPubMedCentral Schnorr JJ, Xanthakos S, Keikavoussi P, Kämpgen E, ter Meulen V, Schneider-Schaulies S (1997) Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A 94:5326–5331CrossRefPubMedPubMedCentral
Zurück zum Zitat Torisu H, Kusuhara K, Kira R, Bassuny WM, Sakai Y, Sanefuji M, Takemoto M, Hara T (2004) Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 62:457–460CrossRefPubMed Torisu H, Kusuhara K, Kira R, Bassuny WM, Sakai Y, Sanefuji M, Takemoto M, Hara T (2004) Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 62:457–460CrossRefPubMed
Zurück zum Zitat Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133–146CrossRefPubMed Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133–146CrossRefPubMed
Zurück zum Zitat Yalaz K, Anlar B, Renda Y, Aysun S, Topcu M, Özdirim E (1988) Subacute sclerosing panencephalitis in Turkey: epidemiological features. J Trop Pediatr 34:301–305CrossRefPubMed Yalaz K, Anlar B, Renda Y, Aysun S, Topcu M, Özdirim E (1988) Subacute sclerosing panencephalitis in Turkey: epidemiological features. J Trop Pediatr 34:301–305CrossRefPubMed
Zurück zum Zitat Yentur SP, Gurses C, Demirbilek V, Yilmaz G, Onal AE, Yapici Z, Yalcinkaya C, Cokar O, Gokyigit A, Saruhan-Direskeneli G (2005) Alterations in cell-mediated immune response in subacute sclerosing panencephalitis. J Neuroimmunol 170:179–185CrossRefPubMed Yentur SP, Gurses C, Demirbilek V, Yilmaz G, Onal AE, Yapici Z, Yalcinkaya C, Cokar O, Gokyigit A, Saruhan-Direskeneli G (2005) Alterations in cell-mediated immune response in subacute sclerosing panencephalitis. J Neuroimmunol 170:179–185CrossRefPubMed
Zurück zum Zitat Yilmaz V, Demirbilek V, Gürses C, Yentür SP, Uysal S, Yapici Z, Yilmaz G, Muncey A, Cokar O, Onal E, Gökyiğit A, Saruhan-Direskeneli G (2007) Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13:410–415CrossRefPubMed Yilmaz V, Demirbilek V, Gürses C, Yentür SP, Uysal S, Yapici Z, Yilmaz G, Muncey A, Cokar O, Onal E, Gökyiğit A, Saruhan-Direskeneli G (2007) Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13:410–415CrossRefPubMed
Metadaten
Titel
Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients
verfasst von
Nihal Olgac Dundar
Pinar Gencpinar
Nilgun Sallakci
Ozgur Duman
Senay Haspolat
Banu Anlar
Olcay Yegin
Publikationsdatum
01.10.2016
Verlag
Springer International Publishing
Erschienen in
Journal of NeuroVirology / Ausgabe 5/2016
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-016-0442-7

Weitere Artikel der Ausgabe 5/2016

Journal of NeuroVirology 5/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.